Quantitative analysis of mRNA of Intraductal papillary mucinous neoplasms: To differentiate carcinoma from benign neoplasms
导管内乳头状粘液性肿瘤 mRNA 的定量分析:区分癌与良性肿瘤
基本信息
- 批准号:17591412
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Intraductal papillary mucinous neoplasms(IPMN) are common cystic tumors of the pancreas and are known to show transition from adenoma to carcinoma accompanied by several molecular abnormalities. The prognosis of patients with intraductal papillary mucinous carcinoma is poor. It is very important to make a early diagnosis of carcinoma to reduce the mortality of the patients. We used quantitative real-time reverse transcription-PCR with gene specific priming to measure MUC1, MUC4, MUC5AC, MUC6, SlOOP, S100A11, Sonic hedghog(SHH), hTERT in various types of pancreatic tumours.The quantitative analyses of MUC1, MUC5AC, S 100P, S100A11 and SHH are useful for differentiation between neoplasms and non-neoplastic lesions. There is significant differences in the expression of hTERT between carcinoma and IPMN. The hTERT analysis of pancreatic juice may provide some advantages for the follow-up of a subset of patients with IPMN.
导管内乳头状粘液性肿瘤是胰腺常见的囊性肿瘤,可由腺瘤转变为癌,并伴有多种分子异常。导管内乳头状黏液腺癌预后差。早期诊断对降低患者死亡率具有重要意义。应用实时定量逆转录聚合酶链反应(real-time reverse transcription-PCR,RT-PCR)结合基因特异性引物,检测了不同类型胰腺肿瘤组织中MUC 1、MUC 4、MUC 5AC、MUC 6、S100 P、S100 A11、S10 hTERT在肿瘤和IPMN中的表达存在显著差异。胰液的hTERT分析可能为IPMN患者亚组的随访提供一些优势。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SlOOP is early Developmental marker of pancreatic carcinogenesis
SlOOP是胰腺癌发生的早期发展标志物
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Ohuchida K;Nagai E et al.
- 通讯作者:Nagai E et al.
S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis
- DOI:10.1158/1078-0432.ccr-06-0222
- 发表时间:2006-09-15
- 期刊:
- 影响因子:11.5
- 作者:Ohuchida, Kenoki;Mizumoto, Kazuhiro;Tanaka, Masao
- 通讯作者:Tanaka, Masao
Sonic hedgehog is an early development marker of intraductal papillary mucinous neoplasms : clinical implications of mRNA levels in pancreatic juice
Sonic Hedgehog是导管内乳头状粘液性肿瘤的早期发展标志物:胰液中mRNA水平的临床意义
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Ohuchida K;Nagai E et al.
- 通讯作者:Nagai E et al.
Quantative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of Pancreatic cancer
胰液中MUC1和MUC5AC mRNA的定量分析用于胰腺癌术前诊断
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Ohuchida K;Nagai E et al.
- 通讯作者:Nagai E et al.
Sl00A11, A putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis
Sl00A11,一种假定的肿瘤抑制基因,在胰腺癌发生过程中过度表达
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Ohuchida K;Nagai E et al.
- 通讯作者:Nagai E et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAGAI Eishi其他文献
NAGAI Eishi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAGAI Eishi', 18)}}的其他基金
Analysis of pancreatic cancer metastasis-promoting microenvironment induced by neutrophil extracellular traps
中性粒细胞胞外陷阱诱导的胰腺癌促转移微环境分析
- 批准号:
18K08685 - 财政年份:2018
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel treatment of pancreatic cancer through microRNA management using a drug delivery system by artificial virus.
一种通过人工病毒药物输送系统管理 microRNA 的新型胰腺癌治疗方法。
- 批准号:
15K15498 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Refractory cancer therapy development by cancer microenvironment elucidation and new drug delivery system based on autophagy
通过癌症微环境阐明和基于自噬的新药物递送系统开发难治性癌症治疗
- 批准号:
25293287 - 财政年份:2013
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel therapies that focus on autophagy-induced cancer cell substrate clearance function
开发专注于自噬诱导的癌细胞底物清除功能的新疗法
- 批准号:
25670587 - 财政年份:2013
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The development of pancreatic cancer therapy based on regulating pancreatic cancer desmoplasia by targeting pancreatic stellate cells to improve drug delivery
通过靶向胰腺星状细胞改善药物输送来调节胰腺癌结缔组织形成的胰腺癌治疗的发展
- 批准号:
23659652 - 财政年份:2011
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Investigation the mechanism and the role of RNA activation by micro RNA in pancreatic cancer
研究微小RNA激活RNA的机制和在胰腺癌中的作用
- 批准号:
22390258 - 财政年份:2010
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Quantitative and functional analysis of mRNA using formalin fixedparaffin embedded samples of IPMN -Innovation for new treatmentof IPMN-
使用福尔马林固定石蜡包埋的 IPMN 样品对 mRNA 进行定量和功能分析 -IPMN 新疗法的创新 -
- 批准号:
19591593 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Adenovirus-mediated Smad4 gene transfer inhibit.s tumor growth and metastasis of human pancreatic carcinoma
腺病毒介导的Smad4基因转移抑制人胰腺癌的肿瘤生长和转移
- 批准号:
14571211 - 财政年份:2002
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Advancing Systematic Delivery of Oncolytic Adenovirus for Pancreatic Cancer
推进溶瘤腺病毒治疗胰腺癌的系统递送
- 批准号:
10734709 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Stress adaptation in obesity-associated pancreatic cancer
肥胖相关胰腺癌的压力适应
- 批准号:
10581170 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
A novel dual-carrier ultrasmall nanomedicine for the treatment of stroma-rich pancreatic cancer
一种用于治疗富含基质的胰腺癌的新型双载体超小纳米药物
- 批准号:
10759720 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
靶向 A2B 腺苷受体用于胰腺癌的免疫预防
- 批准号:
10929664 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment
研究 GLI 转录因子作为胰腺癌微环境的调节剂
- 批准号:
10681714 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Improving response prediction to neoadjuvant therapy in pancreatic cancer
改善胰腺癌新辅助治疗的反应预测
- 批准号:
10784272 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer
R21 MPI microRNA 定向疗法治疗早期胰腺癌
- 批准号:
10577609 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Quantitative Imaging of OXPHOS in Pancreatic Cancer
胰腺癌中 OXPHOS 的定量成像
- 批准号:
10649885 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别: